172 related articles for article (PubMed ID: 2662763)
1. Recent advances in pathophysiology and treatment of hypercalcemia of malignancy.
Mundy GR; Yates AJ
Am J Kidney Dis; 1989 Jul; 14(1):2-12. PubMed ID: 2662763
[No Abstract] [Full Text] [Related]
2. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
Mosekilde L; Eriksen EF; Charles P
Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia of malignancy: a review of advances in pathophysiology.
Kaplan M
Oncol Nurs Forum; 1994 Jul; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and treatment of hypercalcemia of malignancy.
Clines GA
Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia of malignancy: pathophysiology and treatment.
Adami S; Rossini M
Bone; 1992; 13 Suppl 1():S51-5. PubMed ID: 1581120
[TBL] [Abstract][Full Text] [Related]
6. Cancer-induced hypercalcemia.
Coward DD
Cancer Nurs; 1986 Jun; 9(3):125-32. PubMed ID: 3636175
[No Abstract] [Full Text] [Related]
7. Hypercalcemia: pathophysiology and treatment.
Levine MM; Kleeman CR
Hosp Pract (Off Ed); 1987 Jul; 22(7):93-110. PubMed ID: 3110195
[No Abstract] [Full Text] [Related]
8. Hypercalcemia of malignancy.
Mundy GR; Guise TA
Am J Med; 1997 Aug; 103(2):134-45. PubMed ID: 9274897
[No Abstract] [Full Text] [Related]
9. [The pathogenesis of the humoral hypercalcemia syndrome in patients with solid tumors].
Naafs MA; Silberbusch J
Ned Tijdschr Geneeskd; 1989 May; 133(21):1065-9. PubMed ID: 2662028
[No Abstract] [Full Text] [Related]
10. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
11. [Hypercalcemia and skeletal engagement in malignancy--development and therapeutic possibilities].
Ljunghall S; Bergh J; Rastad J; Akerström G
Lakartidningen; 1989 May; 86(21):1991-3. PubMed ID: 2733514
[No Abstract] [Full Text] [Related]
12. Cancer and hypercalcemia of malignancy: a change in focus.
Muggia F
Semin Oncol; 1991 Aug; 18(4 Suppl 5):1-2. PubMed ID: 1925623
[No Abstract] [Full Text] [Related]
13. [Hyper-i hypocalcemia; physiopathological and clinical aspects].
Kokot F
Pol Arch Med Wewn; 1977 Mar; 57(3):215-32. PubMed ID: 322107
[No Abstract] [Full Text] [Related]
14. [Metabolic bone diseases: malignancy-associated hypercalcemia].
Hamada M; Takeda R
Nihon Rinsho; 1986 Nov; 44(11):2467-72. PubMed ID: 3546802
[No Abstract] [Full Text] [Related]
15. Is there a role for parathyroid hormone in humoral hypercalcemia of malignancy?
Stewart AF
Miner Electrolyte Metab; 1982; 8(3-4):215-26. PubMed ID: 6300632
[No Abstract] [Full Text] [Related]
16. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandins and the hypercalcemia of cancer.
Raisz LG
N Engl J Med; 1973 Jul; 289(4):214-5. PubMed ID: 4712993
[No Abstract] [Full Text] [Related]
18. [Recent progress in the pathogenesis and treatment of neoplastic hypercalcemia].
Body JJ; Borkowski A
Rev Med Brux; 1985 Feb; 6(2):81-4. PubMed ID: 3157210
[No Abstract] [Full Text] [Related]
19. Parathyroid hormone-related peptide and hypercalcemia of malignancy.
Goltzman D; Henderson JE
Cancer Treat Res; 1997; 89():193-215. PubMed ID: 9204194
[No Abstract] [Full Text] [Related]
20. Mechanisms of cancer-induced hypercalcemia.
Rosol TJ; Capen CC
Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
